|
 |
| PLAY > New Plays |
Sunday, March 04, 2001 |
 |
New Split Plays
None
New Candidate Plays
| KRI
- Knight-Ridder, Inc. $60.75 (+2.71) |
Stock market investors have been engaging in a frantic search to find any stock in which they can confidently invest. We have had success recently finding companies outside of the technology universe that have been rallying higher on good momentum. Knight-Ridder, our latest potential winner, is a publisher of daily newspapers that also manages a news bureau information wire. Some of the company's better known properties include The Philadelphia Inquirer, The Miami Herald and The Detroit Free Press. Silicon Valley denizens have long been familiar with another one of the company's papers, The San Jose Mercury News. KRI also created SiliconValley.com, which is partnered with the San Jose Mercury News. These two KRI properties are highly respected for their ability to report about the cutting edge developments emanating from the technology center of this country. KRI was one of only a handful of stocks to establish a new high on Friday. Momentum traders may drive KRI much higher if the stock can trade above resistance of $61.25 on Monday with first hour volume over 250,000 shares. A positive start to the week will also likely result in a buy signal being triggered by the MACD. There is also resistance at the all time high of $65.00, which was established in October of 1999. Considering the dearth of momentum trading options in this market, it is not surprising that KRI's Money Flow and OBV are very strong. We see excellent support being provided by the 20-DMA of $59.25. We are additionally encouraged by the fact that the RSI has plenty of room to the upside before the stock would be considered overbought.
New Momentum Plays
| PHCC
- Priority Healthcare Corporation $42.50 (+4.12) |
Priority Healthcare Corporation is a national specialty pharmacy and distribution company that provides specialized pharmaceutical services for patients with chronic diseases or genetic disorders that require high-cost, complex therapies. This weekend we welcomed PHCC to our list of momentum plays on the heels of the stock achieving a new 52-week high of $43.75 on Friday. Let's back up a bit to the events leading up to the new high. On February 22nd PHCC released their most recent earnings report which came in one cent above expectations. Since that date PHCC has risen 22% and now looks poised to move even higher. This has been a great year for investors of PHCC, since December the stock has nearly doubled in value; from a mid-December low of $22.89 to Friday's high of $43.75. The only dark cloud hanging over PHCC's new high was the fact that volume came in slightly lower than the average. Normally PHCC trades about 541,000 shares based on a three-month average, but Friday's high was recorded on volume of only 491,000. So going into next week we will look for volume to build as PHCC attempts new highs. Possible entry points might include a bounce off support at $42.00 or a new move higher to $44.00. We'd like to see volume of 400,000 traded by midday when considering starting a new position. Additional support exists at the 5-dma at $41.00, should the consolidation area at $42.00 fail. Look for additional support from the NASDAQ Composite Index (COMPX) and the CBOE Health Care Index (HCX.X) when considering starting a new play. We will post a stop loss at $39.00 on this play.
New Plays Index
|
|